chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Abdominal pain, Abdominal pain upper, Acute abdomen, Alanine aminotransferase normal, Aspartate aminotransferase increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood albumin normal, Blood alkaline phosphatase normal, Blood amylase decreased, Blood bilirubin normal, Blood calcium increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood chloride decreased, Blood creatinine normal, Blood glucose normal, Blood magnesium normal, Blood phosphorus normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Body temperature increased, Carbon dioxide normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chills, Colectomy, Computerised tomogram abnormal, Fatigue, Gamma-glutamyltransferase
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Haematocrit decreased, Haemoglobin decreased, Intestinal mass, Lymph node pain, Lymphadenopathy
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Mononucleosis heterophile test negative, Platelet count normal, Protein total normal, White blood cell count
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Abdominal pain, Abdominal pain lower, Abdominal wall cyst, Appendix disorder, Blood amylase
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Body temperature increased, Chills, Colectomy, Computerised tomogram abnormal, Condition aggravated
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Fatigue, Full blood count normal, Laboratory test normal, Liver function test normal, Lymph node pain
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Lymphadenopathy, Mass, Mononucleosis heterophile test negative, Tenderness
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342659. A 29 year-old male subject received ACAM2000 (lot number VV04003A) on 10 March 2009. Ten days after vaccination, the patient presented with a tender, enlarged left submandibular lymph node. He was treated with MOTRIN. By Day 13, lymphadenopathy had largely resolved. He note new symptoms of chills and fatigue which began two days prior, lasted for approximately one hour per day and occurred postprandially. The patient was asymptomatic at this visit so no therapy was prescribed. On Day 14, the patient presented with worsening chills and fatigue. CBC, chemistry and liver function panel were within normal limits. A monospot test was negative. The patient returned to the clinic 5 hours later with rigors and new onset belly pain in the right lower quadrant (RLQ). His oral temperature was 101.1 degrees Fahrenheit. The patient was transported to the hospital. A CT of the abdomen revealed a 3 mm cystic lesion at the base of the appendix. A right hemicolectomy was performed to remove an suspicious mass found on the lumen side of the bowel wall just distal to the ileocecal junction. The specimen was sent for evaluation. The patient tolerated the surgery well. On Day 15, the patient was in stable condition. No additional information was reported. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Catheterisation cardiac, Dyspnoea, Electrocardiogram normal, Hyperhidrosis, Myocarditis
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Myocardial infarction, Troponin I increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Arterial occlusive disease, Catheterisation cardiac abnormal, Chest pain, Dyspnoea, Echocardiogram normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Electrocardiogram normal, Hyperhidrosis, Myocarditis, Pain, Pyrexia
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Myocardial infarction, Troponin I
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343051. A 36-year-old patient received the following vaccinations on 30 January 2009: ACAM2000 (lot number not reported), and anthrax (manufacturer not reported, lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twelve days post vaccination the patient awoke with chest pain radiating left arm, shortness of breath and diaphoresis. The pain lessened until late in the same afternoon when the pain exacerbated. He went to an aid station and was diagnosed with panic attack, however his blood pressure was 160/116. He was treated with oxygen and nitrogen and transferred to a local hospital where an electrocardiogram was normal and troponin was elevated. He was admitted to the cardiac care unit and underwent a cardiac catheterization which revealed a small occlusion of the distal left anterior descending artery, otherwise normal coronaries. He was transferred to a step down unit and was given PNEUMOVAX. He developed a fever of 103.8 degrees Fahrenheit within a few hours that lasted 24 hours and then resolved. His initial diagnoses of myocardial infarction and panic attack were changed to post-vaccinia myocarditis after an echocardiogram performed on 26/Mar/2009 was normal. His medication was changed and he was released to home and not deployed. The outcome of this event was not reported. For the event of fever there may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. The narrative specifies that the fever developed after receipt of PNEUMOVAX which was not the same day as the other reported adverse events. List of documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Catheterisation cardiac, Dyspnoea, Electrocardiogram normal, Hyperhidrosis, Myocarditis
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Myocardial infarction, Troponin I increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Arterial occlusive disease, Catheterisation cardiac abnormal, Chest pain, Dyspnoea, Echocardiogram normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Electrocardiogram normal, Hyperhidrosis, Myocarditis, Pain, Pyrexia
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, PPV, SMALL, SMALL
Symptoms: Myocardial infarction, Troponin I
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 343682. A 36 year-old male patient received ACAM2000 (lot number unknown) on 30 January 2009. Eighteen days later, the patient was reported to have a subendocardial infarction. The patient had a Troponin I drawn on 11 February 2009 which was reported as abnormal. No additional information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pain, Pruritus, Vaccinia
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343058.  A 20-year-old patient received the following vaccination on 02 March 2009:  smallpox VACCINIA (ACAM2000, lot number VV045003A).  Seven days post- vaccination the patient experienced itchy bumps on hands and elbows that caused pain when touched rated 5 out of 10 on a pain scale.  She was seen in the emergency room on 18 March 2009, diagnosed with general VACCINIA and treated with LIDEX Cream twice per day as needed.  Laboratory testing performed included a liquid-based cytology cervical smear which was negative and an human immunodeficiency virus antibody test which was also negative.  Medical records received showed dates of service from 18 March 2009 to 27 April 2009 but it is unclear whether the patient was hospitalized.  The final diagnosis reported was erythema multiforme.  The patient's outcome was reported as recovered.  No other information was reported.  List of documents held by sender:  none.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema multiforme, Generalised vaccinia, HIV antibody negative, Laboratory test normal, Pain
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343058.  A 20-year-old patient received the following vaccination on 02 March 2009:  smallpox VACCINIA (ACAM2000, lot number VV045003A).  Seven days post- vaccination the patient experienced itchy bumps on hands and elbows that caused pain when touched rated 5 out of 10 on a pain scale.  She was seen in the emergency room on 18 March 2009, diagnosed with general VACCINIA and treated with LIDEX Cream twice per day as needed.  Laboratory testing performed included a liquid-based cytology cervical smear which was negative and an human immunodeficiency virus antibody test which was also negative.  Medical records received showed dates of service from 18 March 2009 to 27 April 2009 but it is unclear whether the patient was hospitalized.  The final diagnosis reported was erythema multiforme.  The patient's outcome was reported as recovered.  No other information was reported.  List of documents held by sender:  none.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash pruritic, Smear cervix normal, Urticaria
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343058.  A 20-year-old patient received the following vaccination on 02 March 2009:  smallpox VACCINIA (ACAM2000, lot number VV045003A).  Seven days post- vaccination the patient experienced itchy bumps on hands and elbows that caused pain when touched rated 5 out of 10 on a pain scale.  She was seen in the emergency room on 18 March 2009, diagnosed with general VACCINIA and treated with LIDEX Cream twice per day as needed.  Laboratory testing performed included a liquid-based cytology cervical smear which was negative and an human immunodeficiency virus antibody test which was also negative.  Medical records received showed dates of service from 18 March 2009 to 27 April 2009 but it is unclear whether the patient was hospitalized.  The final diagnosis reported was erythema multiforme.  The patient's outcome was reported as recovered.  No other information was reported.  List of documents held by sender:  none.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Blood cholesterol normal, Blood creatine phosphokinase normal, Blood immunoglobulin G, Blood immunoglobulin M, Blood triglycerides normal
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Chest X-ray normal, Chest pain, Computerised tomogram normal, Coxsackie virus serology test negative, Cytomegalovirus antibody negative
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Echocardiogram, Echocardiogram abnormal, Ejection fraction decreased, Fatigue, Fibrin D dimer increased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Herpes simplex serology negative, High density lipoprotein decreased, Influenza serology negative, Low density lipoprotein, Parvovirus B19 serology positive
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Red blood cell sedimentation rate increased, Scan myocardial perfusion, Troponin I increased, Very low density lipoprotein, Virus serology test
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 343456. A 30-year-old patient received the following vaccination on 06 March 2009: ACAM2000 (lot number VV04-003-A). On 11 March 2009 the patient received anthrax (manufacturer not reported, lot number not reported). On 17 March 2009, eleven days post smallpox vaccination and five days post anthrax vaccination, the patient reported feeling fatigued and had non-positional chest pain rated between 1 and 2 on a pain scale of 10. The pain worsened with exertion and inspiration. The patient also reported vomiting and itching on left arm around the smallpox vaccination site. On 18 March 2009 the chest pain was reported as 2 out of 10, constant and increasing with inspiration and non-positional. No vomiting was reported. On 20 March 2009 the chest pain worsened to a 6 out of 10 and was sharp with inspiration, remaining non-positional. The patient went to the emergency room for evaluation. The diagnosis of myopericarditis likely secondary to smallpox vaccine was made. The following laboratory results were reported: 19 March 2009: D Dimer:532 (H) reference rage >230 ng/mL H; troponin I: 0.31 (H); creatinine kinase: 151 reference range 30-200 IU/L; 20 March 2009 (0155): troponin I: 0.33 (H); (0841) 0.23 (H); cholesterol:142; triglycerides: 84; high density lipoprotein:34; low density lipoprotein: 91; very low density lipoprotein: 17; non high density lipoprotein cholesterol: 108 and sedimentation rate: 3/20. Reference ranges were not provided for every test. The outcome of the event was not reported. NOTE: The following additional test results were reported in the event at fields but not in the free text narrative field in the data reported: 17 March 2009: echocardiogram: abnormal, decreased ejection fraction; chest x-ray: normal; electrocardiogram: abnormal; parvovirus B19 serology positive. List of documents held by sender: None.